Rationale and design of the Home Automatic External Defibrillator Trial (HAT)

Gust H. Bardy, Kerry L. Lee, Daniel B. Mark, Jeanne E. Poole, William D. Toff, Andrew M. Tonkin, Warren Smith, Paul Dorian, Julie J. Yallop, Douglas L Packer, Roger D. White, Will Longstreth, Jill Anderson, George Johnson, Eric Bischoff, Crystal D. Munkers, Amanda Brown, Steven McNulty, Linda Davidson Ray, Nancy E. Clapp-ChanningYves Rosenberg, Marcel Salive, Eleanor B. Schron

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Most cardiac arrests occur in the home, where emergency medical services (EMS) systems are challenged to provide timely care. Because a large proportion of sudden cardiac arrests (SCAs) are due to ventricular tachycardia or ventricular fibrillation, home use of an automated external defibrillator (AED) might offer an opportunity to decrease mortality in those at risk. Predicting who will have a cardiac arrest in the general population is difficult. Individuals at high risk are usually easily identified and may become candidates for implantable cardioverter defibrillators. It is within the population at lower risk where home AEDs may be most useful. The purpose of the Home Automatic External Defibrillator Trial (HAT) is to test whether providing home access to an AED can improve survival in patients at modest risk of SCA, such as those surviving an anterior myocardial infarction but in whom implantable cardioverter defibrillator therapy is not deemed necessary. Between January 23, 2003, and October 20, 2005, 7001 patients were enrolled, with completion of follow-up scheduled for September 30, 2007. Randomization was conducted in a 1:1 fashion between control therapy, comprising the standard lay response to SCA (calling the EMS and performing cardiopulmonary resuscitation), and the use of an AED first, followed by calling the EMS and performing cardiopulmonary resuscitation. The primary end point is all-cause mortality. Secondary outcomes include survival from SCA (witnessed and unwitnessed, in home and out of home), incremental cost-effectiveness, and quality of life measures for both the patient and the spouse/companion. The results of the trial should be available in mid 2008.

Original languageEnglish (US)
Pages (from-to)445-454
Number of pages10
JournalAmerican Heart Journal
Volume155
Issue number3
DOIs
StatePublished - Mar 2008

Fingerprint

Defibrillators
Sudden Cardiac Death
Emergency Medical Services
Implantable Defibrillators
Cardiopulmonary Resuscitation
Heart Arrest
Survival
Mortality
Ventricular Fibrillation
Ventricular Tachycardia
Random Allocation
Spouses
Cost-Benefit Analysis
Myocardial Infarction
Quality of Life
Therapeutics
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Toff, W. D., Tonkin, A. M., ... Schron, E. B. (2008). Rationale and design of the Home Automatic External Defibrillator Trial (HAT). American Heart Journal, 155(3), 445-454. https://doi.org/10.1016/j.ahj.2007.12.008

Rationale and design of the Home Automatic External Defibrillator Trial (HAT). / Bardy, Gust H.; Lee, Kerry L.; Mark, Daniel B.; Poole, Jeanne E.; Toff, William D.; Tonkin, Andrew M.; Smith, Warren; Dorian, Paul; Yallop, Julie J.; Packer, Douglas L; White, Roger D.; Longstreth, Will; Anderson, Jill; Johnson, George; Bischoff, Eric; Munkers, Crystal D.; Brown, Amanda; McNulty, Steven; Ray, Linda Davidson; Clapp-Channing, Nancy E.; Rosenberg, Yves; Salive, Marcel; Schron, Eleanor B.

In: American Heart Journal, Vol. 155, No. 3, 03.2008, p. 445-454.

Research output: Contribution to journalArticle

Bardy, GH, Lee, KL, Mark, DB, Poole, JE, Toff, WD, Tonkin, AM, Smith, W, Dorian, P, Yallop, JJ, Packer, DL, White, RD, Longstreth, W, Anderson, J, Johnson, G, Bischoff, E, Munkers, CD, Brown, A, McNulty, S, Ray, LD, Clapp-Channing, NE, Rosenberg, Y, Salive, M & Schron, EB 2008, 'Rationale and design of the Home Automatic External Defibrillator Trial (HAT)', American Heart Journal, vol. 155, no. 3, pp. 445-454. https://doi.org/10.1016/j.ahj.2007.12.008
Bardy, Gust H. ; Lee, Kerry L. ; Mark, Daniel B. ; Poole, Jeanne E. ; Toff, William D. ; Tonkin, Andrew M. ; Smith, Warren ; Dorian, Paul ; Yallop, Julie J. ; Packer, Douglas L ; White, Roger D. ; Longstreth, Will ; Anderson, Jill ; Johnson, George ; Bischoff, Eric ; Munkers, Crystal D. ; Brown, Amanda ; McNulty, Steven ; Ray, Linda Davidson ; Clapp-Channing, Nancy E. ; Rosenberg, Yves ; Salive, Marcel ; Schron, Eleanor B. / Rationale and design of the Home Automatic External Defibrillator Trial (HAT). In: American Heart Journal. 2008 ; Vol. 155, No. 3. pp. 445-454.
@article{ba71a670cfe646f98f363681d239c661,
title = "Rationale and design of the Home Automatic External Defibrillator Trial (HAT)",
abstract = "Most cardiac arrests occur in the home, where emergency medical services (EMS) systems are challenged to provide timely care. Because a large proportion of sudden cardiac arrests (SCAs) are due to ventricular tachycardia or ventricular fibrillation, home use of an automated external defibrillator (AED) might offer an opportunity to decrease mortality in those at risk. Predicting who will have a cardiac arrest in the general population is difficult. Individuals at high risk are usually easily identified and may become candidates for implantable cardioverter defibrillators. It is within the population at lower risk where home AEDs may be most useful. The purpose of the Home Automatic External Defibrillator Trial (HAT) is to test whether providing home access to an AED can improve survival in patients at modest risk of SCA, such as those surviving an anterior myocardial infarction but in whom implantable cardioverter defibrillator therapy is not deemed necessary. Between January 23, 2003, and October 20, 2005, 7001 patients were enrolled, with completion of follow-up scheduled for September 30, 2007. Randomization was conducted in a 1:1 fashion between control therapy, comprising the standard lay response to SCA (calling the EMS and performing cardiopulmonary resuscitation), and the use of an AED first, followed by calling the EMS and performing cardiopulmonary resuscitation. The primary end point is all-cause mortality. Secondary outcomes include survival from SCA (witnessed and unwitnessed, in home and out of home), incremental cost-effectiveness, and quality of life measures for both the patient and the spouse/companion. The results of the trial should be available in mid 2008.",
author = "Bardy, {Gust H.} and Lee, {Kerry L.} and Mark, {Daniel B.} and Poole, {Jeanne E.} and Toff, {William D.} and Tonkin, {Andrew M.} and Warren Smith and Paul Dorian and Yallop, {Julie J.} and Packer, {Douglas L} and White, {Roger D.} and Will Longstreth and Jill Anderson and George Johnson and Eric Bischoff and Munkers, {Crystal D.} and Amanda Brown and Steven McNulty and Ray, {Linda Davidson} and Clapp-Channing, {Nancy E.} and Yves Rosenberg and Marcel Salive and Schron, {Eleanor B.}",
year = "2008",
month = "3",
doi = "10.1016/j.ahj.2007.12.008",
language = "English (US)",
volume = "155",
pages = "445--454",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Rationale and design of the Home Automatic External Defibrillator Trial (HAT)

AU - Bardy, Gust H.

AU - Lee, Kerry L.

AU - Mark, Daniel B.

AU - Poole, Jeanne E.

AU - Toff, William D.

AU - Tonkin, Andrew M.

AU - Smith, Warren

AU - Dorian, Paul

AU - Yallop, Julie J.

AU - Packer, Douglas L

AU - White, Roger D.

AU - Longstreth, Will

AU - Anderson, Jill

AU - Johnson, George

AU - Bischoff, Eric

AU - Munkers, Crystal D.

AU - Brown, Amanda

AU - McNulty, Steven

AU - Ray, Linda Davidson

AU - Clapp-Channing, Nancy E.

AU - Rosenberg, Yves

AU - Salive, Marcel

AU - Schron, Eleanor B.

PY - 2008/3

Y1 - 2008/3

N2 - Most cardiac arrests occur in the home, where emergency medical services (EMS) systems are challenged to provide timely care. Because a large proportion of sudden cardiac arrests (SCAs) are due to ventricular tachycardia or ventricular fibrillation, home use of an automated external defibrillator (AED) might offer an opportunity to decrease mortality in those at risk. Predicting who will have a cardiac arrest in the general population is difficult. Individuals at high risk are usually easily identified and may become candidates for implantable cardioverter defibrillators. It is within the population at lower risk where home AEDs may be most useful. The purpose of the Home Automatic External Defibrillator Trial (HAT) is to test whether providing home access to an AED can improve survival in patients at modest risk of SCA, such as those surviving an anterior myocardial infarction but in whom implantable cardioverter defibrillator therapy is not deemed necessary. Between January 23, 2003, and October 20, 2005, 7001 patients were enrolled, with completion of follow-up scheduled for September 30, 2007. Randomization was conducted in a 1:1 fashion between control therapy, comprising the standard lay response to SCA (calling the EMS and performing cardiopulmonary resuscitation), and the use of an AED first, followed by calling the EMS and performing cardiopulmonary resuscitation. The primary end point is all-cause mortality. Secondary outcomes include survival from SCA (witnessed and unwitnessed, in home and out of home), incremental cost-effectiveness, and quality of life measures for both the patient and the spouse/companion. The results of the trial should be available in mid 2008.

AB - Most cardiac arrests occur in the home, where emergency medical services (EMS) systems are challenged to provide timely care. Because a large proportion of sudden cardiac arrests (SCAs) are due to ventricular tachycardia or ventricular fibrillation, home use of an automated external defibrillator (AED) might offer an opportunity to decrease mortality in those at risk. Predicting who will have a cardiac arrest in the general population is difficult. Individuals at high risk are usually easily identified and may become candidates for implantable cardioverter defibrillators. It is within the population at lower risk where home AEDs may be most useful. The purpose of the Home Automatic External Defibrillator Trial (HAT) is to test whether providing home access to an AED can improve survival in patients at modest risk of SCA, such as those surviving an anterior myocardial infarction but in whom implantable cardioverter defibrillator therapy is not deemed necessary. Between January 23, 2003, and October 20, 2005, 7001 patients were enrolled, with completion of follow-up scheduled for September 30, 2007. Randomization was conducted in a 1:1 fashion between control therapy, comprising the standard lay response to SCA (calling the EMS and performing cardiopulmonary resuscitation), and the use of an AED first, followed by calling the EMS and performing cardiopulmonary resuscitation. The primary end point is all-cause mortality. Secondary outcomes include survival from SCA (witnessed and unwitnessed, in home and out of home), incremental cost-effectiveness, and quality of life measures for both the patient and the spouse/companion. The results of the trial should be available in mid 2008.

UR - http://www.scopus.com/inward/record.url?scp=39249085617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39249085617&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2007.12.008

DO - 10.1016/j.ahj.2007.12.008

M3 - Article

C2 - 18294476

AN - SCOPUS:39249085617

VL - 155

SP - 445

EP - 454

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 3

ER -